Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Stem Cell

California Voters Pass $5.5b Stem Cell Research Measure Funding Ongoing Grants from California Institute for Regenerative Medicine

Publicly funded stem cell research in California received backing by the populace recently with the passage of Proposition 14, the California […]

California Voters Pass $5.5b Stem Cell Research Measure Funding Ongoing Grants from California Institute for Regenerative Medicine
3 months ago
Share

Icahn School of Medicine Cardiovascular Regenerative Therapy Investigator Receives $2.9m to Investigate Stem Cell Regenerative Powers

The potential of regenerative therapies will be explored thanks to a recently announced $2.9 million grant from the National Institutes […]

Icahn School of Medicine Cardiovascular Regenerative Therapy Investigator Receives $2.9m to Investigate Stem Cell Regenerative Powers
3 months ago
Share

Hackensack University Medical Center Offers Clinical Trial to Investigate Nerve Recovery Post Robotic Prostatectomy for Prostate Cancer

Hackensack Meridian Hackensack University Medical Center’s Department of Urology is among the first in the nation to embrace bioregenerative medicine as […]

Hackensack University Medical Center Offers Clinical Trial to Investigate Nerve Recovery Post Robotic Prostatectomy for Prostate Cancer
5 months ago
Share

First Patient Treated in Phase 1 Study Involving Cord Blood-derived Natural Killer Cells in Combo with AFM13 (Innate Cell Engager)

Humans may have an innate ability to fight off cancer and one of the world’s most prominent research centers, University […]

First Patient Treated in Phase 1 Study Involving Cord Blood-derived Natural Killer Cells in Combo with AFM13 (Innate Cell Engager)
5 months ago
Share

Children’s Hospital Los Angeles Investigators Secure $4m for Regenerative Research & Cell Therapeutics

Two prominent researchers from the Saban Research Institute of Children’s Hospital Los Angeles haves secured over $4 million from the […]

Children’s Hospital Los Angeles Investigators Secure $4m for Regenerative Research & Cell Therapeutics
6 months ago
Share

Remestemcel-L Available under FDA EAP for COVID-19 Infected Children with Cardiovascular & Other Severe Complications

Mesoblast Limited (ASX:MSB; Nasdaq:MESO) initiated an expanded access protocol (EAP) in the United States for compassionate use of its allogeneic […]

Remestemcel-L Available under FDA EAP for COVID-19 infected Children with Cardiovascular & Other Severe Complications
8 months ago
Share

AVM Planning Clinical Trial to Compare AVM0703 to Dexamethasone in Severe COVID-19 Cases

AVM Biotechnology, based in Seattle, is a development-stage biotech venture seeking to ultimately commercialize “game-changing” stem cell technologies for high unmet […]

AVM Planning Clinical Trial to Compare AVM0703 to Dexamethasone in Severe COVID-19 Cases
8 months ago
Share

Las Vegas-Based Exosome Rogue Biotech Endangering the Public: FDA Hits with Warning Letter

The U.S. Food and Drug Administration issued a warning letter to EUCYT Laboratories LLC, for first and foremost marketing an […]

Las Vegas-Based Exosome Rogue Biotech Endangering the Public FDA Hits with Warning Letter
9 months ago
Share

SUNY Binghamton Dept of Biomedical Engineering Researchers on the Move Securing Millions in Grants

Binghamton University is one of four university centers in the State University of New York (SUNY) system. Founded originally as a […]

SUNY Binghamton Dept of Biomedical Engineering Researchers on the Move Securing Millions in GrantsSUNY Binghamton Dept of Biomedical Engineering Researchers on the Move Securing Millions in Grants
9 months ago
Share

Landmark Hospitals Compassionate Use Study for Critical COVID-19 Patients Evidences Potential for Allogenic Biologic Product

Landmark Hospital manages six long-term acute care hospitals across the Southeast United States and recently announced its decision to offer an […]

Landmark Hospital's Compassionate Use Study for Critical COVID-19 Patients Evidences Potential for Allogeneic Biologic Product
9 months ago
Share

Posts navigation

Older posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.